Nowadays, measurement of serum CA125 is considered essential for monitoring response to treatment (Van der Berg et al, 1988; Tuxen et al, 1995; Rustin et al, 1996) but has a limited value for general population screening (Tuxen et al, 1995; Zanotti and Kennedy, 1999).